Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis
BackgroundAlopecia areata (AA) is a chronic immune-mediated disorder causing non-scarring hair loss. Severe forms like alopecia totalis (AT) and alopecia universalis (AU) pose therapeutic difficult situations. Topical immunotherapy with squaric acid dibutylester (SADBE) and diphenylcyclopropenone (D...
Saved in:
| Main Authors: | Taiyo Hitaka, Sanehito Haruyama, Shun Ohmori, Natsuko Saito-Sasaki, Etsuko Okada, Motonobu Nakamura, Yu Sawada |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1573929/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of comorbid Crohn’s disease and alopecia universalis with upadacitinib and oral minoxidil
by: Jasmine Levine, et al.
Published: (2025-12-01) -
Alopecia areata in solid organ transplant recipients: A retrospective analysis
by: Isabella Roman, BS, et al.
Published: (2025-06-01) -
Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
by: Yijie Sun, et al.
Published: (2025-06-01) -
Bowing of the Legs and Alopecia Universalis in a Young Boy
by: Kittu Malhi, et al.
Published: (2025-01-01) -
A Novel Hope for Alopecia Totalis Patients: Case Report
by: Manal Elsayed, et al.
Published: (2020-11-01)